Impact of vaccines and vaccination on global control of avian influenza
- PMID: 23402099
- DOI: 10.1637/10183-041012-Review.1
Impact of vaccines and vaccination on global control of avian influenza
Abstract
There are 30 recorded epizootics of H5 or H7 high pathogenicity avian influenza (HPAI) from 1959 to early 2012. The largest of these epizootics, affecting more birds and countries than the other 29 epizootics combined, has been the H5N1 HPAI, which began in Guangdong China in 1996, and has killed or resulted in culling of over 250 million poultry and/or wild birds in 63 countries. Most countries have used stamping-out programs in poultry to eradicate H5N1 HPAI. However, 15 affected countries have utilized vaccination as a part of the control strategy. Greater than 113 billion doses were used from 2002 to 2010. Five countries have utilized nationwide routine vaccination programs, which account for 99% of vaccine used: 1) China (90.9%), 2) Egypt (4.6%), 3) Indonesia (2.3%), 4) Vietnam (1.4%), and 5) Hong Kong Special Administrative Region (< 0.01%). Mongolia, Kazakhstan, France, The Netherlands, Cote d'Ivoire, Sudan, North Korea, Israel, Russia, and Pakistan used < 1% of the avian influenza (AI) vaccine, and the AI vaccine was targeted to either preventive or emergency vaccination programs. Inactivated AI vaccines have accounted for 95.5% of vaccine used, and live recombinant virus vaccines have accounted for 4.5% of vaccine used. The latter are primarily recombinant Newcastle disease vectored vaccine with H5 influenza gene insert. China, Indonesia, Egypt, and Vietnam implemented vaccination after H5N1 HPAI became enzootic in domestic poultry. Bangladesh and eastern India have enzootic H5N1 HPAI and have not used vaccination in their control programs. Clinical disease and mortality have been prevented in chickens, human cases have been reduced, and rural livelihoods and food security have been maintained by using vaccines during HPAI outbreaks. However, field outbreaks have occurred in vaccinating countries, primarily because of inadequate coverage in the target species, but vaccine failures have occurred following antigenic drift in field viruses within China, Egypt, Indonesia, Hong Kong, and Vietnam. The primary strategy for HPAI and H5/H7 low pathogenicity notifiable avian influenza control will continue to be immediate eradication using a four-component strategy: 1) education, 2) biosecurity, 3) rapid diagnostics and surveillance, and 4) elimination of infected poultry. Under some circumstances, vaccination can be added as an additional tool within a wider control strategy when immediate eradication is not feasible, which will maintain livelihoods and food security, and control clinical disease until a primary strategy can be developed and implemented to achieve eradication.
Similar articles
-
Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination.Rev Sci Tech. 2011 Dec;30(3):839-70. doi: 10.20506/rst.30.3.2081. Rev Sci Tech. 2011. PMID: 22435196
-
Current status and future needs in diagnostics and vaccines for high pathogenicity avian influenza.Dev Biol (Basel). 2013;135:79-94. doi: 10.1159/000325276. Epub 2013 May 14. Dev Biol (Basel). 2013. PMID: 23689886
-
Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agricultural interface.Ecohealth. 2014;11(1):94-108. doi: 10.1007/s10393-013-0861-3. Epub 2013 Sep 12. Ecohealth. 2014. PMID: 24026475 Review.
-
Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza.Ann N Y Acad Sci. 2006 Oct;1081:174-81. doi: 10.1196/annals.1373.021. Ann N Y Acad Sci. 2006. PMID: 17135509 Review.
-
Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.J Virol. 2015 Apr;89(7):3746-62. doi: 10.1128/JVI.00025-15. Epub 2015 Jan 21. J Virol. 2015. PMID: 25609805 Free PMC article.
Cited by
-
Temporal and Emotional Variations in People's Perceptions of Mass Epidemic Infectious Disease After the COVID-19 Pandemic Using Influenza A as an Example: Topic Modeling and Sentiment Analysis Based on Weibo Data.J Med Internet Res. 2023 Nov 2;25:e49300. doi: 10.2196/49300. J Med Internet Res. 2023. PMID: 37917144 Free PMC article.
-
Single Dose of Bivalent H5 and H7 Influenza Virus-Like Particle Protects Chickens Against Highly Pathogenic H5N1 and H7N9 Avian Influenza Viruses.Front Vet Sci. 2021 Nov 11;8:774630. doi: 10.3389/fvets.2021.774630. eCollection 2021. Front Vet Sci. 2021. PMID: 34859093 Free PMC article.
-
Contact between bird species of different lifespans can promote the emergence of highly pathogenic avian influenza strains.Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10767-72. doi: 10.1073/pnas.1401849111. Epub 2014 Jun 23. Proc Natl Acad Sci U S A. 2014. PMID: 24958867 Free PMC article.
-
Zoonotic Animal Influenza Virus and Potential Mixing Vessel Hosts.Viruses. 2023 Apr 16;15(4):980. doi: 10.3390/v15040980. Viruses. 2023. PMID: 37112960 Free PMC article. Review.
-
Single Dose of Consensus Hemagglutinin-Based Virus-Like Particles Vaccine Protects Chickens against Divergent H5 Subtype Influenza Viruses.Front Immunol. 2017 Nov 27;8:1649. doi: 10.3389/fimmu.2017.01649. eCollection 2017. Front Immunol. 2017. PMID: 29230222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical